Medicinal products for gene therapies
Titre original de l'avis
Spain – Various medicinal products – Suministro de medicamentos destinado a terapias genicas mediante SDA
Score d'opportunité
Pourquoi ce score ?
Opportunité
60 / 100
Complexité
55 / 100
Facteurs de risque
Selection criteria require annual turnover and references; not meeting thresholds could disqualify.
DPS may have many competitions; each may require separate submission with short deadlines.
Restricted procedure — pre-qualification required
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Aperçu
Strong opportunityFaits clés
- EUR 65.8M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 2 lots
- Duration until Apr 2031
- Supply of advanced gene therapy medicinal products for spinal muscular atrophy and hemophilia B.
- Destined for patients of the Canary Health Service (Servicio Canario de la Salud).
Afficher le résumé complet
This tender is for a Dynamic Purchasing System (DPS) for the supply of advanced gene therapy medicines for spinal muscular atrophy (SMA) and hemophilia B to patients of the Canary Health Service. The DPS is divided into two lots with a total estimated value of €65,765,376. The procedure is restricted, award is based solely on price (100% weight), and submissions are electronic in Spanish. Tenderers may only bid for one lot.
Risques
Selection criteria require annual turnover and references; not meeting thresholds could disqualify.
DPS may have many competitions; each may require separate submission with short deadlines.
Restricted procedure — pre-qualification required
L'analyse peut être incomplète
Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.
Exigences clés
Administrative
- Restricted procedure: only invited candidates may submit tenders.
- Electronic submission is required.
- All documents must be in Spanish.
Les exigences peuvent être incomplètes.
Critères d'attribution
Lot 1
Lot 2
Acheteur
Localisation
Las Palmas de Gran Canaria, ESP
Profil acheteur
Identifiant
21058580149618
Activité
Health
Lots (2)
LOT-0001
Terapia génica para la atrofia muscular espinal
Supply of gene therapy for spinal muscular atrophy (SMA).
EUR 65.8M
Valeur estimée
Localisation
Durée
Catégorie
Critères d'attribution
Détails des critères
precio. . Precio.
Note sur la valeur
Afficher les données TED originales
Description TED originale
Terapia génica para la atrofia muscular espinal
LOT-0002
Terapia génica para la hemofilia B
Supply of gene therapy for hemophilia B.
EUR 65.8M
Valeur estimée
Localisation
Durée
Catégorie
Critères d'attribution
Détails des critères
precio. . Price.
Note sur la valeur
Afficher les données TED originales
Description TED originale
Terapia génica para la hemofilia B
Détails de la procédure
- Date de publication
- 19 Apr 2026
- Langues
- Spanish
Métadonnées de référence
- Base juridique
- 32014L0024
Identifiants de référence
- ID de l'appel d'offres
- 267052-2026
Documents (1)
Appels d'offres similaires
Poland – Various medicinal products – Dostawa produktów leczniczych, nr PN-127/26/TM
France – Pharmaceutical products – 26-10 : ACCORD-CADRE DE FOURNITURE DE MÉDICAMENTS 2026
Belgium – Various medicinal products – Leveren van paracetamol oplossing voor intraveneus gebruik voor de ziekenhuisapotheek
Belgium – Medicinal products for the respiratory system – LEVEREN VAN PIRFENIDONE 267 mg en 801 mg (filmomhulde) tabletten
Belgium – Anaesthetics – LEVEREN VAN ROCURONIUM 50 MG/ 5 ML VOOR INTRAVENEUS GEBRUIK
France – Various medicinal products – FOURNITURE DE MEDICAMENTS RADIOPHARMACEUTIQUES (TEP et SCINTI) ______________________________________________________________________
Score d'opportunité
Pourquoi ce score ?
Opportunité
60 / 100
Complexité
55 / 100
Facteurs de risque
Selection criteria require annual turnover and references; not meeting thresholds could disqualify.
DPS may have many competitions; each may require separate submission with short deadlines.
Restricted procedure — pre-qualification required
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications